Lifevantage Gross Margin 2010-2024 | LFVN
Current and historical gross margin for Lifevantage (LFVN) over the last 10 years. The current gross profit margin for Lifevantage as of September 30, 2024 is %.
Lifevantage Gross Margin Historical Data |
Date |
TTM Revenue |
TTM Gross Profit |
Gross Margin |
2024-09-30 |
$0.20B |
$0.16B |
79.59% |
2024-06-30 |
$0.20B |
$0.16B |
79.50% |
2024-03-31 |
$0.21B |
$0.16B |
79.51% |
2023-12-31 |
$0.21B |
$0.17B |
79.62% |
2023-09-30 |
$0.21B |
$0.17B |
79.34% |
2023-06-30 |
$0.21B |
$0.17B |
79.44% |
2023-03-31 |
$0.21B |
$0.17B |
80.09% |
2022-12-31 |
$0.21B |
$0.17B |
80.19% |
2022-09-30 |
$0.21B |
$0.17B |
81.46% |
2022-06-30 |
$0.21B |
$0.17B |
82.04% |
2022-03-31 |
$0.21B |
$0.17B |
81.90% |
2021-12-31 |
$0.21B |
$0.18B |
82.55% |
2021-09-30 |
$0.22B |
$0.18B |
82.65% |
2021-06-30 |
$0.22B |
$0.18B |
82.35% |
2021-03-31 |
$0.23B |
$0.19B |
83.11% |
2020-12-31 |
$0.23B |
$0.19B |
83.41% |
2020-09-30 |
$0.23B |
$0.19B |
83.55% |
2020-06-30 |
$0.23B |
$0.20B |
84.05% |
2020-03-31 |
$0.23B |
$0.19B |
83.41% |
2019-12-31 |
$0.23B |
$0.19B |
83.41% |
2019-09-30 |
$0.23B |
$0.19B |
83.19% |
2019-06-30 |
$0.23B |
$0.19B |
82.74% |
2019-03-31 |
$0.22B |
$0.19B |
83.48% |
2018-12-31 |
$0.22B |
$0.18B |
83.11% |
2018-09-30 |
$0.21B |
$0.17B |
82.86% |
2018-06-30 |
$0.20B |
$0.17B |
82.76% |
2018-03-31 |
$0.20B |
$0.16B |
82.00% |
2017-12-31 |
$0.19B |
$0.16B |
81.96% |
2017-09-30 |
$0.19B |
$0.16B |
82.47% |
2017-06-30 |
$0.20B |
$0.17B |
83.00% |
2017-03-31 |
$0.20B |
$0.17B |
83.17% |
2016-12-31 |
$0.21B |
$0.18B |
83.10% |
2016-09-30 |
$0.22B |
$0.18B |
83.33% |
2016-06-30 |
$0.21B |
$0.17B |
83.50% |
2016-03-31 |
$0.20B |
$0.17B |
83.84% |
2015-12-31 |
$0.19B |
$0.16B |
84.49% |
2015-09-30 |
$0.18B |
$0.16B |
84.70% |
2015-06-30 |
$0.19B |
$0.16B |
85.79% |
2015-03-31 |
$0.20B |
$0.17B |
85.57% |
2014-12-31 |
$0.21B |
$0.18B |
85.78% |
2014-09-30 |
$0.22B |
$0.18B |
85.58% |
2014-06-30 |
$0.21B |
$0.18B |
85.05% |
2014-03-31 |
$0.21B |
$0.18B |
85.24% |
2013-12-31 |
$0.21B |
$0.18B |
85.85% |
2013-09-30 |
$0.21B |
$0.17B |
83.01% |
2013-06-30 |
$0.21B |
$0.17B |
82.69% |
2013-03-31 |
$0.20B |
$0.17B |
82.59% |
2012-12-31 |
$0.19B |
$0.15B |
81.82% |
2012-09-30 |
$0.16B |
$0.14B |
85.53% |
2012-06-30 |
$0.13B |
$0.11B |
85.71% |
2012-03-31 |
$0.10B |
$0.08B |
86.46% |
2011-12-31 |
$0.07B |
$0.06B |
85.71% |
2011-09-30 |
$0.05B |
$0.04B |
84.62% |
2011-06-30 |
$0.04B |
$0.03B |
84.21% |
2011-03-31 |
$0.03B |
$0.02B |
85.19% |
2010-12-31 |
$0.02B |
$0.02B |
85.00% |
2010-09-30 |
$0.02B |
$0.01B |
86.67% |
2010-06-30 |
$0.01B |
$0.01B |
90.91% |
2010-03-31 |
$0.01B |
$0.01B |
77.78% |
2009-12-31 |
$0.01B |
$0.01B |
85.71% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical & Dental Supplies |
$0.175B |
$0.200B |
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
|